Physician profile
George E Eigbire
NPI 1093165367
$17,665.79
in general payments reported to CMS, 2019-2025
21 companies · $2,790 in 2025
The $2,790 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $806 · 2021: $1,878 · 2022: $5,843 · 2023: $1,778 · 2024: $4,348 · 2025: $2,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $6,317 · Food and Beverage: $1,625 · Travel and Lodging: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $6,316.67 |
| Food and Beverage | $1,624.72 |
| Travel and Lodging | $974.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $6,316.67 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $4,419.69 | 2019-2025 | Xience Skypoint, Coroflow, Diamondback Peripheral |
| Boston Scientific Corporation | $3,186.96 | 2022 | |
| Abiomed | $1,097.55 | 2020-2023 | Impella |
| Philips North America LLC | $974.36 | 2023 | (9520) Igt Devices Undivided |
| Shockwave Medical, INC | $300.45 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $287.50 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $255.78 | 2021-2023 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $151.03 | 2019-2024 | Farxiga |
| Lantheus Medical Imaging, INC. | $115.29 | 2023 | Definity |
| Zoll Circulation INC | $114.01 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Medtronic, INC. | $99.87 | 2023-2025 | Ffrangio, Hawkone |
| Amgen INC. | $76.28 | 2021-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $70.79 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $57.20 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.70 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $33.59 | 2020 | |
| Teleflex LLC | $23.01 | 2023 | Vascband |
| Kestra Medical Technology Services, INC. | $19.00 | 2022 | |
| Terumo Medical Corporation | $17.27 | 2020 | |
| Chiesi USA, INC. | $15.79 | 2024 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Eigbire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.